Gliadel (Arbor Pharmaceuticals)


Welcome to the PulseAid listing for the Gliadel drug offered from Arbor Pharmaceuticals. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Arbor Pharmaceuticals
NON-PROPRIETARY NAME: carmustine
SUBSTANCE NAME: CARMUSTINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: INTRACAVITARY
DOSAGE FORM: WAFER
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2012-12-13
END MARKETING DATE: 0000-00-00


Gliadel HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGliadel from Arbor Pharmaceuticals
LABELER NAME: Arbor Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 7.7(mg/1)
START MARKETING DATE: 2012-12-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 24338-050_69c3cd33-3b38-488f-ac50-e06d96a2a721
PRODUCT NDC: 24338-050
APPLICATION NUMBER: NDA020637

Other CARMUSTINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Arbor PharmaceuticalsGliadel